EUCTR2006-001109-28-GB进行中（未招募）1 期
Perhexiline therapy in patients with heart failure with preserved left ventricular ejection fraction(HFpEF syndrome) - HFpEF
niversity of Aberdeen0 个研究点目标入组 72 人开始时间: 2006年9月18日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Clinical features consistant with heart failure
- •LVEF>50%,with no evidence of significant valvular disease, no
- •hypertrophic cardiomyopathy, and no ebvidence of pericardial
- •constriction.
- •A peak VO2 of <80% predicted, with a pattern of gas exchange on
- •metabolic Exercise testing indicating a cardiac cause for limiktation.
- •In sinus rhythm
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •Abnormal liver function tests, pre-existing peripheral neuropathy,
- •concomitant use of amiodarone and women of childbearing potential,
- •objective evidence of lung disease on formal lung function tests
研究者
相似试验
进行中（未招募）
1 期
Myocardial protection with Perhexiline in Left Ventricular Hypertrophy - Perhexiline in LVHPatients with left ventricular hypertrophy undergoing aortic valve surgery (with or without coronary artery surgery)EUCTR2008-002376-95-GBniversity Hospital Birmingham NHS Foundation Trust220
进行中（未招募）
不适用
Perhexiline therapy in patients with Hypertrophic CardiomyopathyHypertrophic CardiomyopathyEUCTR2005-000755-15-GBniversity Hospital of Birmingham Foundation Trust50
尚未招募
不适用
Clinical study on intervention of heart failure patients after myocardial infarction with Wuqinxi based on the theory of ''supporting yang''Postinfarction heart failureITMCTR2022000105Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine
已完成
不适用
Heart failure revascularisatioHeart failure with left ventricular systolic dysfunctionCirculatory SystemISRCTN86284615Medical Research Council (MRC) (UK)800
进行中（未招募）
1 期
Empagliflozin in heart failure patients with reduced ejection fraction:A randomized clinical trial (Empire HF)EUCTR2017-001341-27-DKMorten Schou190